Advertisements

Hidroxido de Aluminio

Quick links to important sections

Hidroxido de Aluminio

Advertisements
Advertisements

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Hidroxido de Aluminio

What is Aluminum Hydroxide?

Aluminum hydroxide is an inorganic compound used primarily as an antacid to manage symptoms of upper gastrointestinal discomfort. It is a basic salt that works through chemical neutralization rather than systemic absorption.

Chemical Nature and Mechanism

As an antacid, aluminum hydroxide functions by reacting with the hydrochloric acid produced in the stomach. This chemical reaction converts the gastric acid into aluminum chloride and water, thereby increasing the pH level of the stomach contents. By reducing the overall acidity, the compound helps to diminish the proteolytic activity of pepsin, which can contribute to the irritation of the esophageal and gastric linings.

Primary Uses

Aluminum hydroxide is typically utilized for the symptomatic relief of conditions associated with hyperacidity. These may include:

  • Heartburn: The sensation of burning in the chest caused by acid reflux.
  • Acid Indigestion: General discomfort or pain in the upper digestive tract related to digestive acids.
  • Sour Stomach: A condition characterized by an overproduction of gastric acid.

Physical Properties

In its medicinal form, aluminum hydroxide is often found as a dried gel or a suspension. One of its distinguishing characteristics compared to other antacids is its relatively slow onset of action and its tendency to provide a more prolonged neutralizing effect. Unlike some carbonate-based antacids, aluminum hydroxide does not produce carbon dioxide gas during the neutralization process, which minimizes the occurrence of secondary symptoms like belching or bloating.

Regulatory References

  1. Aluminum Hydroxide - StatPearls - NCBI Bookshelf
Advertisements

What side effects are possible with Hidroxido de Aluminio?

Possible Side Effects and Safety Information

This section details the officially documented adverse reactions and safety constraints for Hidroxido de Aluminio (Aluminum Hydroxide) as described in regulatory and government-approved prescribing information.

Common and Less Common Adverse Reactions

The most frequently documented adverse effect is Constipation, classified as an Uncommon reaction in some regulatory summaries, and falling under Gastrointestinal disorders. Less common effects may include nausea and vomiting.

Metabolic and Serious Safety Risks

The official safety profile is structured around two key metabolic risks:

  • Hypophosphatemia (Phosphate Depletion): This is a documented risk, especially with excessive doses or long-term use, which can lead to more serious conditions like Osteomalacia (softening of the bones).
  • Hyperaluminemia (Aluminum Accumulation): This risk is significantly elevated in patients with Renal Impairment or Kidney Failure due to the body's inability to excrete aluminum.

Documented serious adverse reactions linked to this toxicity include Encephalopathy (brain damage) and Microcytic Anemia.

Population-Specific Safety Constraints

Official labeling imposes strict constraints based on specific patient populations and duration of use:

Safety Constraint Population or Condition
Contraindicated Patients with pre-existing Hypophosphatemia or Kidney Failure
Increased Risk Elderly patients (Constipation, Intestinal Obstruction)
Duration Limit Use beyond two weeks requires professional supervision

These constraints ensure the risk of systemic toxicity, particularly in patients with compromised kidney function, is acknowledged and managed according to regulatory standards.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

Overdose manifestations for Aluminum Hydroxide (Hidroxido de Aluminio) are officially documented based on the type of exposure. Acute manifestations following a large ingestion primarily involve the gastrointestinal tract, including abdominal pain, vomiting, and diarrhea.

A more severe, long-term overdose profile is associated with chronic use or large doses, particularly in patients with impaired kidney function. This systemic toxicity can lead to phosphate depletion (hypophosphatemia), which may present with muscle weakness, anorexia, and confusion. Severe, life-threatening outcomes formally documented in regulatory labeling include encephalopathy (brain damage) resulting from aluminum accumulation, and mechanical complications such as intestinal obstruction.


Immediate Actions and Emergency Requirements

Regulatory labeling mandates that individuals seek emergency medical attention or contact a Poison Control Center right away for any suspected overdose. Immediate medical help is also required if symptoms such as a swollen face, difficulty breathing, or signs of intestinal obstruction occur. Management procedures described in official documents focus on symptomatic and supportive treatment, with specialized measures like haemodialysis or peritoneal dialysis necessary to clear accumulated aluminum and magnesium in patients with renal deficiencies.

Advertisements

Therapeutic Uses of Hidroxido de Aluminio

Quick Facts: What Hidroxido de Aluminio Treats

  • Relieves: Symptoms of acid indigestion, heartburn, and sour stomach.
  • Used for: Managing elevated phosphate levels in individuals with certain kidney conditions.
  • Contributes to: Symptomatic relief in cases of peptic ulcer, gastritis, and reflux.

Hidroxido de Aluminio, commonly known as aluminum hydroxide, is a medication used to provide symptomatic relief for conditions related to excess stomach acid. The primary therapeutic domains include managing discomfort associated with acid indigestion, heartburn, and sour stomach. It may also be used to help alleviate symptoms of gastroesophageal reflux disease (GERD), gastritis, and peptic ulcer.

In a distinct application, this compound is administered to manage high levels of phosphate in the blood, a condition known as hyperphosphatemia, which may occur in individuals with specific kidney disorders. The medication is generally available without a prescription for its antacid uses. Always consult with a healthcare professional to ensure appropriate use. It may be used alone or in combination with other therapeutic agents to achieve symptomatic support.

Advertisements

Eligibility and Restrictions for Use

Official Eligibility Rules for Hidroxido de Aluminio

The eligibility for using Hidroxido de Aluminio (Aluminum Hydroxide) is strictly defined by regulatory documents, focusing on patient age, underlying health conditions, and physiological state.

Contraindicated Populations Use is Prohibited
Kidney Failure (Renal Insufficiency) Due to risk of aluminum accumulation [HPRA]
Hypophosphatemia (Low Phosphate) Risk of worsening phosphate deficiency [Rwanda FDA]
Hypersensitivity Known allergy to the active ingredient [Rwanda FDA]
Severely Debilitated Patients Avoidance advised [HPRA]

Age-Related Eligibility

Age Group Regulatory Statement
Adults Approved for general antacid use and specific use as a phosphate binder [MedlinePlus]
Children under 12 Not recommended for routine use; requires physician consultation [HPRA]
Older Adults Normal adult dose is applicable, but caution is necessary due to the increased risk of age-related renal impairment and fecal impaction [HPRA]

Condition-Specific Restrictions

Use requires caution or is restricted in patients with a predisposition to constipation, fecal impaction, or bowel obstruction risk. Caution is also advised for patients with heart failure, edema, or cirrhosis [Rwanda FDA]. Prolonged use is not recommended in patients with renal impairment due to the risk of aluminum toxicity [HPRA].

Pregnancy and Lactation Eligibility Status

The safety of use during pregnancy is not established, and it is not recommended unless clearly needed [[Drugs.com/FDA]() Label]. During lactation, no adverse effects on the infant are anticipated, but monitoring is sometimes advised [HPRA].

The official eligibility structure classifies patients based on metabolic status and organ function, ensuring that use is limited to approved populations where risks, such as aluminum accumulation or phosphate depletion, are minimized.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official Interaction Profile

The interaction profile for Hidroxido de Aluminio (Aluminum Hydroxide) is primarily defined by its ability to physically bind to other substances in the gastrointestinal tract, a mechanism that officially alters the systemic exposure of co-administered medicines.

Exposure-Altering Interactions (Reduced Absorption):

Co-administration with this medicine may significantly reduce the bioavailability and plasma concentration of several agents, a finding documented in regulatory labeling. Interacting agents include Fluoroquinolone antibiotics (such as Ciprofloxacin), Tetracycline antibiotics, and Bisphosphonates. Immediate release formulations of Gabapentin also experience a reduction in bioavailability upon co-administration.

Interaction-Related Restrictions and Timing Rules:

To mitigate the risk of reduced exposure, official regulatory documents mandate the separation of doses. The administration of Aluminum Hydroxide must be separated from many interacting medicines by at least two to four hours. Similarly, doses should be separated from Enteric-Coated Pancreatic Enzymes by at least one hour to prevent premature enzyme destruction.

Population-Specific Caution (Citrates):

The combination with Citrates (found in foods, juices, and effervescent medicinal products) is contraindicated or generally avoided in patients with renal impairment. This is due to the enhanced absorption of aluminum, leading to a significant risk of aluminum toxicity (hyperaluminemia) in individuals with impaired clearance.

Advertisements

Mechanism of Action

Chemical Modulation of Gastric Acidity

Hidróxido de Aluminio operates through a peripheral, local mechanism as a chemical neutralizer within the stomach lumen. The compound reacts directly with hydrochloric acid ( HCl), consuming hydrogen ions ( H^+) and elevating the stomach's pH. This alteration reduces the chemical irritation of the HCl on the mucosa and inhibits the proteolytic activity of the enzyme pepsin, which requires a highly acidic environment to function. This results in a modification of the chemical environment in the upper gastrointestinal tract.

Regulation of Dietary Phosphate Absorption

Its second distinct mechanism is as an intestinal chelator. The aluminum component binds to dietary inorganic phosphate ions ( PO4^3-) present in the gastrointestinal tract, forming an insoluble complex known as aluminum phosphate. This complex cannot be absorbed by the intestinal mucosa and is excreted. This modulation of intestinal uptake directly affects systemic mineral homeostasis, facilitating a net reduction in the concentration of serum phosphate.

Advertisements

Dosage and Administration Information

How to Use Hidroxido de Aluminio

Hidroxido de Aluminio (Aluminum Hydroxide) is administered via the oral route for its primary therapeutic applications. It is available mainly as an oral suspension and chewable tablets, and administration is tailored to the specific indication.


Dosing and Frequency

Indication Adult Dose Range Frequency and Timing Key Instruction
Antacid Use 5 mL to 30 mL of suspension (or tablet equivalent) Up to 5 to 6 times daily; Between meals and at bedtime Do not use for more than 2 weeks.
Phosphate Binding 300 mg to 600 mg (PO) Three times daily Take the dose with meals.

Administration Requirements

Proper use requires specific steps to ensure effectiveness and appropriate absorption:

  • Preparation: The oral suspension is shaken well before each dose is measured. Chewable tablets are chewed thoroughly before swallowing.
  • Timing with Other Drugs: To prevent reduced absorption of other medicines, the administration of Aluminum Hydroxide and other oral drugs is separated by at least 2 hours.
  • Duration Limit: For antacid use, the maximum recommended dosage is not used continuously for more than two weeks unless directed by a healthcare professional.

Population-Specific Use

Pediatric dosing is individualized for phosphate binding and requires professional titration. For over-the-counter (OTC) antacid use, use in children under 12 years requires consultation with a doctor.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Hidroxido de Aluminio

Evidence for Use in Acid-Related Symptomatic Relief

Research evaluating Aluminum Hydroxide has focused on conditions characterized by episodic or acute manifestations of stomach acid, such as heartburn, acid indigestion, and associated symptoms of peptic ulcer and gastritis. This evidence base involves primarily short-term Randomized Controlled Trials (RCTs) and therapeutic comparisons. Researchers monitored patient-reported outcomes describing physical discomfort and measured the short-term duration of acid-neutralizing activity.

In these trials, findings describe patterns observed in the measurement of patient-reported symptom intensity. Research contributes to the available findings on symptom patterns during periods of heightened activity. However, the data often show patterns related to use in fixed-dose combination formulations—for instance, paired with magnesium compounds—consequently, research findings must be interpreted in the context of it being a combination product.

Evidence for Use as a Phosphate Binder

A distinct body of research was evaluated for the compound's use as a phosphate binder, focusing on patients with systemic or functional imbalance. Research explored the measurements of specific blood biomarkers, chiefly serum phosphate levels, in adults with advanced Chronic Kidney Disease (CKD), including those undergoing dialysis. The available evidence is largely derived from Systematic Reviews and Meta-analyses of comparative RCTs.

Studies report data on phosphate levels in the observed populations, and research indicates that the use of this compound was associated with observed shifts in this key biomarker during the study period. Comparative evidence is often based on findings that describe patterns observed relative to newer, non-aluminum phosphate binders.

What is Still Uncertain About Hidroxido de Aluminio Research

A prominent research limitation involves limited long-term data regarding complex clinical outcomes. Past concerns over aluminum accumulation limited the widespread use and subsequent execution of large-scale, extended-duration RCTs. Consequently, certainty remains low regarding the effects on overall survival or cardiovascular endpoints, and comparative evidence against other binders for these long-term outcomes is currently lacking or considered uncertain.

Key Studies & References

  1. Aluminum Hydroxide and Magnesium Hydroxide: MedlinePlus Drug Information (Source for combination product data and use in specific populations)
  2. New Pharmacotherapy Options for Hyperphosphatemia (Discusses aluminum hydroxide no longer being first-line due to toxicity concerns and efficacy relative to others)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Hidroxido de Aluminio (FAQ)

Q: Is Hidroxido de Aluminio the same type of medicine as magnesium antacids?

A: Official documents classify Hidroxido de Aluminio as both an Antacid and a Phosphate Binder. While it belongs to the general class of mineral-based antacids, it is a distinct chemical entity. It is often combined with magnesium compounds in commercial products to balance the effects of the two ingredients on the digestive system.

Q: Why is Hidroxido de Aluminio sometimes combined with other ingredients like magnesium hydroxide or simethicone?

A: Hidroxido de Aluminio is known to carry a risk of constipation. According to product information, the combination with Magnesium Hydroxide is primarily used to help balance the effect on bowel function. Other ingredients, such as Simethicone, may be included in combination products to address symptoms of gas and bloating.

Q: Is it normal to feel a change in bowel movements (like constipation) when taking Hidroxido de Aluminio?

A: Regulatory safety documents list constipation as a commonly documented adverse reaction. This change in bowel movements is a known characteristic of Hidroxido de Aluminio. Official information also notes that the risk of constipation may be higher in older patients.

Q: Are there any specific foods or drinks that should be avoided while taking Hidroxido de Aluminio?

A: Official warnings note that taking this medicine with foods or drinks containing citrates (like citrus fruits and juices) is restricted. Regulatory information indicates that this restriction is necessary for patients with kidney function issues, as citrates are known to significantly increase the absorption of aluminum.

Q: Is the potential for aluminum to build up in the body a concern with long-term use?

A: Official warnings note that prolonged or excessive use of this medicine may lead to aluminum toxicity (hyperaluminemia), which is when aluminum builds up in the body. This risk is particularly elevated for patients who have compromised kidney function, and warnings detail potential serious effects on the brain and bones.

Q: Does the medicine cause a chalky taste, as some users report?

A: Antacid products, particularly the liquid suspension forms, are commonly associated with a chalky taste due to the nature of the active mineral ingredients. Information sometimes suggests that the chalky taste may be managed by taking the dose with a small amount of water or milk, where appropriate for the product.

Q: Does the medicine come in different concentrations or strengths?

A: Hidroxido de Aluminio is available in different forms and dosages. Official dosage instructions reference specific volumes of the liquid suspension or mass of the active ingredient in tablets, which are indicators of variable strength and concentration across different manufactured products.

Q: Can Hidroxido de Aluminio cause fecal discoloration or white speckles in stool?

A: Official regulatory safety information documents that fecal discoloration is a possible adverse effect. This change is sometimes described by users as the stool having a lighter color or containing white speckles.

Q: Are there any studies discussing the safety of the use of aluminum hydroxide as a vaccine adjuvant?

A: Sources linked to official drug information, such as the NCI Thesaurus, recognize the compound Aluminum Hydroxide's use in medicine. It is classified as an adjuvant in certain immunologic preparations, where its role is described as helping to improve the immune response.

Q: Do the official warnings mention any issues for people who frequently drink alcohol?

A: Official regulatory summaries advise that if a person frequently drinks alcohol, they should consult a healthcare professional before taking this medicine.

Q: Is the medicine known to interact with any common antifungal medications?

A: Official regulatory interaction warnings advise that this medicine may decrease the effects of some antifungal medications. For example, official labeling suggests separating the doses of this antacid and antifungals like Itraconazole by two or more hours.

Q: What does the term 'hiatal hernia' mean in the context of this drug's use?

A: A Hiatal Hernia is a medical condition involving the stomach. Some antacid compositions that contain Hidroxido de Aluminio are noted in authoritative texts as being useful in providing symptomatic relief for various gastric disorders, which may include conditions like a hiatal hernia.

Q: Are there warnings about taking Hidroxido de Aluminio if a person is dehydrated?

A: Official regulatory warnings advise consulting a healthcare professional before taking this medicine if the person is currently dehydrated.

Q: Why might a doctor prescribe this drug for a use other than simple stomach acid relief?

A: Beyond its use as an antacid, the medicine is also prescribed as a phosphate binder. In this specialized role, it is used to lower high phosphate levels in the blood, which is a necessary management step for people with chronic kidney conditions, according to official sources like MedlinePlus.

Q: Can Hidroxido de Aluminio interfere with the effectiveness of antibiotics?

A: Regulatory labeling notes that co-administration may reduce the bioavailability and effectiveness of several antibiotics. Specific examples include Fluoroquinolones and Tetracyclines, whose absorption is significantly altered by this antacid.

Q: Is there a required time interval between taking Hidroxido de Aluminio and other oral medications?

A: Official regulatory labeling advises separating the administration of Hidroxido de Aluminio and other oral drugs by at least 2 hours. This is a requirement put in place to help prevent reduced absorption of the other medications.

Q: What should be done if a person experiences unusual tiredness or muscle weakness while using this drug?

A: Official safety instructions indicate that symptoms such as muscle weakness or extreme tiredness may require immediate medical evaluation, and the medicine's use should be discontinued until evaluation occurs. These symptoms may be signs of a serious, documented metabolic risk.

Q: Is it safe to take Hidroxido de Aluminio if a person is on a low-sodium diet?

A: Regulatory warnings advise that patients on a sodium-restricted diet should use the medication with caution. It is recommended that a healthcare professional be consulted to determine if the product's sodium content is appropriate for the individual's dietary restrictions.

Q: Can Hidroxido de Aluminio affect the results of an H. pylori breath test?

A: Clinical reviews and studies indicate that antacids, including Hidroxido de Aluminio, do not impair the sensitivity of the H. pylori breath test. This means taking the antacid is unlikely to interfere with the accurate result of this specific diagnostic test.

Q: Does the medicine interact with any medications used for osteoporosis?

A: Official labeling lists an interaction with Bisphosphonates, a class of medicine commonly used to treat or prevent osteoporosis. To manage this interaction, regulatory instructions advise separating the doses of the two medications.

Q: What is the difference between the liquid suspension and the chewable tablet form of the medicine?

A: The key differences relate to administration requirements. Official instructions state that the oral suspension must be shaken well before each use to ensure proper concentration. In contrast, chewable tablets must be chewed thoroughly before they are swallowed.

Q: Are there research studies or evidence that discuss the use of this medicine for stomach ulcers?

A: Official research overviews confirm that the compound has been evaluated for acid-related conditions. Research has specifically examined the use of Hidroxido de Aluminio to address symptoms associated with conditions such as peptic ulcer.

Q: Can Hidroxido de Aluminio affect the absorption of vitamins or dietary minerals?

A: Official information indicates that the medicine may affect the absorption of vitamins or dietary minerals. It is officially used to bind to and reduce the absorption of the mineral phosphate. Furthermore, regulatory sources note that it may also interfere with the absorption of other nutrients like folic acid and iron.

Q: Is there a maximum amount of time the product can be used without consulting a professional, according to the label?

A: For use as an antacid, official regulatory labeling states that the maximum recommended dosage should not be used continuously for more than two weeks. Use beyond this period requires consultation with a healthcare professional.

Q: Is a loss of appetite listed as a possible side effect of Hidroxido de Aluminio?

A: Official regulatory safety information advises users to contact a healthcare professional at once if they experience signs of a problem, which includes loss of appetite.

Q: Can taking Hidroxido de Aluminio cause a decrease in phosphate levels in the blood?

A: Because Hidroxido de Aluminio binds to phosphate in the gut, official safety profiles document Hypophosphatemia (phosphate depletion) as a known risk. This is a concern that can occur, especially with high doses or prolonged use.

Q: Are there any special considerations for taking this medicine during pregnancy or breastfeeding?

A: Official eligibility information states that the safety of use during pregnancy is not established, and it is not recommended unless clearly needed. During lactation, no adverse effects on the infant are generally anticipated based on available data.

Q: What are the official sources' perspectives on using this drug with chronic diarrhea?

A: Official warnings focus on the risk of constipation, which is a primary side effect of this medicine. Regulatory information advises caution in patients with conditions that predispose them to bowel obstruction, such as pre-existing constipation. Its constipating nature may be used to counteract diarrhea in combination products.

Advertisements

How should Hidroxido de Aluminio be stored and disposed of?

How to Store and Dispose of Hidroxido de Aluminio?

This section outlines the official, label-based requirements for storing and disposing of Hidroxido de Aluminio (Aluminum Hydroxide).


Official Storage Requirements

  • Temperature and Protection: Store the medicine at controlled room temperature, typically 20 C to 25 C. It must be protected from freezing (especially the liquid suspension), moisture, and excess heat.
  • Container Rules: Keep the medicine in its original container and ensure the cap or lid is tightly closed when not in use.
  • Child Safety: It is mandatory to store this medicine out of the sight and reach of children to prevent accidental ingestion.

Official Disposal Instructions

  • Safe Disposal: Unused or expired medication should be disposed of through a medicine take-back program if one is available.
  • Environmental Rule: Do not flush the medicine down the toilet or pour it into a drain to protect the environment and water supply. Disposal must be in accordance with local regulatory guidelines.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Hidroxido de Aluminio found in:

A-Z Index: